Search - tctmd.com

Displaying 101 - 120 of 148

Sort: Relevancy | Date

Presentation EuroPCR 2015

ILUMIEN II: A Retrospective Evaluation of Stent Expansion with OCT Guidance vs IVUS Guidance

Presenter: Gregg Stone

May 22, 2015

Presentation EuroPCR 2015

Two-year results in the Nordic-Baltic bifurcation study IV

Presenter: Indulis Kumsars

May 21, 2015

Presentation EuroPCR 2015

Computed tomographic angiography follow-up and 12-month outcome following balloon angioplasty for isolated penile artery stenoses in patients with erectile dysfunction: the PERFECT-2 study

Presenter: Tzung-Dau Wang

May 20, 2015

Presentation EuroPCR 2015

The NOTION Trial

Presenter: Lars Sondergaard

May 19, 2015

Presentation EuroPCR 2015

The FFR-CT RIPCORD Study

Presenter: Nick Curzen

May 19, 2015

Presentation EuroPCR 2015

Multivessel Coronary Disease Diagnosed at the Time of Primary PCI for STEMI: Complete Revascularization Versus Conservative Strategy - PRAGUE 13 Trial

Presenter: Ota Hlinomaz

May 19, 2015

Presentation EuroPCR 2015

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

Presenter: Sigmund Silber

May 19, 2015

Presentation EuroPCR 2015

Final Three-Year Outcome of a Randomized Trial Comparing Second Generation DES Using Either Biodegradable Polymer or Durable Polyme

Presenter: Masahiro Natsuaki

May 19, 2015

Presentation EuroPCR 2014

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

May 22, 2014

Presentation EuroPCR 2014

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

Presenter: Stephan Windecker

May 22, 2014

Presentation EuroPCR 2014

Final Five Year Outcomes of the NOBORI2 Trial

Presenter: G.B. Danzi

May 22, 2014

Presentation EuroPCR 2014

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Presenter: Jos? Ram?n L?pez-M?nguez

May 21, 2014

$Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial$

Presentation EuroPCR 2014

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Presenter: Uwe Zeymer

May 21, 2014

Presentation EuroPCR 2014

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

Presenter: Hiroyoshi Yokoi

May 21, 2014

Presentation EuroPCR 2014

Primary Results of the Multicenter COBRA Trial

Presenter: Christophe Dubois

May 20, 2014

Presentation EuroPCR 2014

Left Atrial Decompression Through Unidirectional Left-to-Right Shunt for the Treatment of Left Cardiac Failure: Initial Experience with the V-Wave Device

Presenter: Josep Rod?s-Cabau

May 20, 2014

Presentation EuroPCR 2014

BABILON TRIAL: A prospective randomized study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions

Presenter: Jos? Ram?n L?pez-M?nguez

May 20, 2014

Presentation EuroPCR 2013

Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Presenter: 203171|Ian Meredith

May 31, 2013

Presentation EuroPCR 2013

The Next Generation Renal Denervation Technology - The Vessix Device

Presenter: E. Wyffels

May 31, 2013

Presentation EuroPCR 2013

Repositionable Percutaneous Replacement of a Stenotic Aortic Valve through Implantation of the Lotus Valve System

Presenter: 203171|Ian Meredith

May 31, 2013

Advertisement

ILUMIEN II: A Retrospective Evaluation of Stent Expansion with OCT Guidance vs IVUS Guidance

Two-year results in the Nordic-Baltic bifurcation study IV

Computed tomographic angiography follow-up and 12-month outcome following balloon angioplasty for isolated penile artery stenoses in patients with erectile dysfunction: the PERFECT-2 study

The NOTION Trial

The FFR-CT RIPCORD Study

Multivessel Coronary Disease Diagnosed at the Time of Primary PCI for STEMI: Complete Revascularization Versus Conservative Strategy - PRAGUE 13 Trial

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

Final Three-Year Outcome of a Randomized Trial Comparing Second Generation DES Using Either Biodegradable Polymer or Durable Polyme

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

Final Five Year Outcomes of the NOBORI2 Trial

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

Primary Results of the Multicenter COBRA Trial

Left Atrial Decompression Through Unidirectional Left-to-Right Shunt for the Treatment of Left Cardiac Failure: Initial Experience with the V-Wave Device

BABILON TRIAL: A prospective randomized study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions

Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

The Next Generation Renal Denervation Technology - The Vessix Device

Repositionable Percutaneous Replacement of a Stenotic Aortic Valve through Implantation of the Lotus Valve System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content